Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Biochemical studies of poly-T variants in the Alzheimer's disease associated TOMM40 gene.

Hedskog L, Brohede J, Wiehager B, Pinho CM, Revathikumar P, Lilius L, Glaser E, Graff C, Karlström H, Ankarcrona M.

J Alzheimers Dis. 2012;31(3):527-36. doi: 10.3233/JAD-2012-120580.

PMID:
22596268
2.

The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE ε3/ε3 genotype.

Johnson SC, La Rue A, Hermann BP, Xu G, Koscik RL, Jonaitis EM, Bendlin BB, Hogan KJ, Roses AD, Saunders AM, Lutz MW, Asthana S, Green RC, Sager MA.

Alzheimers Dement. 2011 Jul;7(4):456-65. doi: 10.1016/j.jalz.2010.11.012.

3.

Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease.

Cruchaga C, Nowotny P, Kauwe JS, Ridge PG, Mayo K, Bertelsen S, Hinrichs A, Fagan AM, Holtzman DM, Morris JC, Goate AM; Alzheimer's Disease Neuroimaging Initiative.

Arch Neurol. 2011 Aug;68(8):1013-9. doi: 10.1001/archneurol.2011.155.

4.

TOMM40 intron 6 poly-T length, age at onset, and neuropathology of AD in individuals with APOE ε3/ε3.

Li G, Bekris LM, Leong L, Steinbart EJ, Shofer JB, Crane PK, Larson EB, Peskind ER, Bird TD, Yu CE.

Alzheimers Dement. 2013 Sep;9(5):554-61. doi: 10.1016/j.jalz.2012.06.009. Epub 2012 Nov 22.

5.

TOMM40 rs10524523 polymorphism's role in late-onset Alzheimer's disease and in longevity.

Maruszak A, Pepłońska B, Safranow K, Chodakowska-Żebrowska M, Barcikowska M, Zekanowski C.

J Alzheimers Dis. 2012;28(2):309-22. doi: 10.3233/JAD-2011-110743.

PMID:
22008263
6.

The cis-regulatory effect of an Alzheimer's disease-associated poly-T locus on expression of TOMM40 and apolipoprotein E genes.

Linnertz C, Anderson L, Gottschalk W, Crenshaw D, Lutz MW, Allen J, Saith S, Mihovilovic M, Burke JR, Welsh-Bohmer KA, Roses AD, Chiba-Falek O.

Alzheimers Dement. 2014 Sep;10(5):541-51. doi: 10.1016/j.jalz.2013.08.280. Epub 2014 Jan 15.

7.

A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease.

Roses AD, Lutz MW, Amrine-Madsen H, Saunders AM, Crenshaw DG, Sundseth SS, Huentelman MJ, Welsh-Bohmer KA, Reiman EM.

Pharmacogenomics J. 2010 Oct;10(5):375-84. doi: 10.1038/tpj.2009.69. Epub 2009 Dec 22.

8.

Alzheimer's disease susceptibility genes APOE and TOMM40, and brain white matter integrity in the Lothian Birth Cohort 1936.

Lyall DM, Harris SE, Bastin ME, Muñoz Maniega S, Murray C, Lutz MW, Saunders AM, Roses AD, Valdés Hernández Mdel C, Royle NA, Starr JM, Porteous DJ, Wardlaw JM, Deary IJ.

Neurobiol Aging. 2014 Jun;35(6):1513.e25-33. doi: 10.1016/j.neurobiolaging.2014.01.006. Epub 2014 Jan 8.

9.

Characterization of the poly-T variant in the TOMM40 gene in diverse populations.

Linnertz C, Saunders AM, Lutz MW, Crenshaw DM, Grossman I, Burns DK, Whitfield KE, Hauser MA, McCarthy JJ, Ulmer M, Allingham R, Welsh-Bohmer KA, Roses AD, Chiba-Falek O.

PLoS One. 2012;7(2):e30994. doi: 10.1371/journal.pone.0030994. Epub 2012 Feb 16.

10.

TOMM40 poly-T repeat lengths, age of onset and psychosis risk in Alzheimer disease.

Chu SH, Roeder K, Ferrell RE, Devlin B, DeMichele-Sweet MA, Kamboh MI, Lopez OL, Sweet RA.

Neurobiol Aging. 2011 Dec;32(12):2328.e1-9. doi: 10.1016/j.neurobiolaging.2011.06.016. Epub 2011 Aug 5.

11.

The effect of TOMM40 poly-T repeat lengths on age of onset and cerebrospinal fluid biomarkers in Finnish Alzheimer's disease patients.

Helisalmi S, Hall A, Meriläinen EH, Väisänen V, Koivisto AM, Herukka SK, Laitinen M, Soininen H, Hiltunen M.

Neurodegener Dis. 2014;14(4):204-8. doi: 10.1159/000367994. Epub 2014 Dec 4.

PMID:
25500937
12.

The effect of TOMM40 on spatial navigation in amnestic mild cognitive impairment.

Laczó J, Andel R, Vyhnalek M, Matoska V, Kaplan V, Nedelska Z, Lerch O, Gazova I, Moffat SD, Hort J.

Neurobiol Aging. 2015 Jun;36(6):2024-33. doi: 10.1016/j.neurobiolaging.2015.03.004. Epub 2015 Mar 16.

PMID:
25862420
13.

TOMM40 polymorphisms in Italian Alzheimer's disease and frontotemporal dementia patients.

Bagnoli S, Piaceri I, Tedde A, Bessi V, Bracco L, Sorbi S, Nacmias B.

Neurol Sci. 2013 Jun;34(6):995-8. doi: 10.1007/s10072-013-1425-6. Epub 2013 Apr 2.

PMID:
23546992
14.

Longitudinal modeling of cognitive aging and the TOMM40 effect.

Caselli RJ, Dueck AC, Huentelman MJ, Lutz MW, Saunders AM, Reiman EM, Roses AD.

Alzheimers Dement. 2012 Nov;8(6):490-5. doi: 10.1016/j.jalz.2011.11.006.

15.

TOMM40 poly-T variants and cerebrospinal fluid amyloid beta levels in the elderly.

Pomara N, Bruno D, Nierenberg JJ, Sidtis JJ, Martiniuk FT, Mehta PD, Zetterberg H, Blennow K.

Neurochem Res. 2011 Jun;36(6):1124-8. doi: 10.1007/s11064-011-0459-5. Epub 2011 Apr 1.

16.

Cerebrospinal fluid cortisol concentrations in healthy elderly are affected by both APOE and TOMM40 variants.

Bruno D, Nierenberg JJ, Ritchie JC, Lutz MW, Pomara N.

Psychoneuroendocrinology. 2012 Mar;37(3):366-71. doi: 10.1016/j.psyneuen.2011.07.006. Epub 2011 Jul 30.

17.

Levels of cerebrospinal fluid neurofilament light protein in healthy elderly vary as a function of TOMM40 variants.

Bruno D, Pomara N, Nierenberg J, Ritchie JC, Lutz MW, Zetterberg H, Blennow K.

Exp Gerontol. 2012 May;47(5):347-52. doi: 10.1016/j.exger.2011.09.008. Epub 2011 Oct 1.

18.

Alzheimer's disease susceptibility genes APOE and TOMM40, and hippocampal volumes in the Lothian birth cohort 1936.

Lyall DM, Royle NA, Harris SE, Bastin ME, Maniega SM, Murray C, Lutz MW, Saunders AM, Roses AD, del Valdés Hernández MC, Starr JM, Porteous DJ, Wardlaw JM, Deary IJ.

PLoS One. 2013 Nov 15;8(11):e80513. doi: 10.1371/journal.pone.0080513. eCollection 2013.

19.

An inherited variable poly-T repeat genotype in TOMM40 in Alzheimer disease.

Roses AD.

Arch Neurol. 2010 May;67(5):536-41. doi: 10.1001/archneurol.2010.88. Review.

20.

Polymorphism in the TOMM40 gene modifies the risk of developing sporadic inclusion body myositis and the age of onset of symptoms.

Mastaglia FL, Rojana-udomsart A, James I, Needham M, Day TJ, Kiers L, Corbett JA, Saunders AM, Lutz MW, Roses AD; Alzheimer’s Disease Neuroimaging Initiative.

Neuromuscul Disord. 2013 Dec;23(12):969-74. doi: 10.1016/j.nmd.2013.09.008. Epub 2013 Sep 19.

PMID:
24103330
Items per page

Supplemental Content

Write to the Help Desk